CN1346642A - 降糖茶 - Google Patents
降糖茶 Download PDFInfo
- Publication number
- CN1346642A CN1346642A CN 00112591 CN00112591A CN1346642A CN 1346642 A CN1346642 A CN 1346642A CN 00112591 CN00112591 CN 00112591 CN 00112591 A CN00112591 A CN 00112591A CN 1346642 A CN1346642 A CN 1346642A
- Authority
- CN
- China
- Prior art keywords
- tea
- blood
- sugar reducing
- blood sugar
- catechin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001603 reducing effect Effects 0.000 title claims description 12
- 239000008280 blood Substances 0.000 title description 10
- 210000004369 blood Anatomy 0.000 title description 10
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 32
- 235000013616 tea Nutrition 0.000 claims abstract description 27
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims abstract description 13
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000009569 green tea Nutrition 0.000 claims abstract description 10
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 8
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 8
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000049 pigment Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 4
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 3
- 239000011573 trace mineral Substances 0.000 claims abstract description 3
- 150000004676 glycans Chemical class 0.000 claims description 7
- 229920001282 polysaccharide Polymers 0.000 claims description 7
- 239000005017 polysaccharide Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 2
- 239000002674 ointment Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- BNYHRGTXRPWASY-UHFFFAOYSA-N nonylsulfonylurea Chemical compound CCCCCCCCCS(=O)(=O)NC(N)=O BNYHRGTXRPWASY-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229960003243 phenformin Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种降糖茶由切细绿茶等组成,其特征在于在切细绿茶的基础上按一定比例添加了茶多糖(TPS)、茶多酚(色素)、茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)等微量元素,利用切细绿茶的利尿、茶多糖、茶多酚、茶儿茶素的降血糖、降血脂、抗氧化等机理;制成袋装粉剂、水剂或膏剂等,达到标本兼治、易吸收之目的,是防治和治疗糖尿最理想的制剂之一。
Description
本发明涉及一种茶，特别涉及一种用于冶疗糖尿病的降糖茶。
糖尿病是由于身体胰岛素分泌减少，引起糖、脂肪、蛋白质、水和无机盐代谢紊乱，而致血糖升高和排泄糖尿的一种慢性病。病因尚未完全明确，可能与遗传、病毒感染、自身免疫等因素有关。患者多中老年以上。是仅次于癌症的第三大“杀手”。目前，西医采用调节血糖的方法《糖尿病保健新知识》(阎德文著，海天出版社出版)，常见的有：1.磺脲类降糖药，此药刺激胰岛细胞释放胰岛素而发挥降糖作用，通常会将正常血糖降低，发生低血糖症；2.双胍类降糖药{主要有苯乙双胍(降糖灵)、二甲双胍(降糖片)}，此药能延缓葡萄糖在肠道内吸收，但会造成胃肠道反应，出现口干苦、恶心、厌食、腹泻等症状；3.葡萄糖苷酶抑制剂，此药只有当消化道中存在双糖时，才显示它的作用，服药后会出现腹胀、腹泻等消化道反应；4.餐时血糖调节剂，该药是进一步快速促进胰岛细胞释放胰岛素的非磺脲类药物，该药必须在就餐时同时服用，影响食欲，使用不方便。中医药诊治糖尿病(《糖尿病及其并发症中西医诊治学》，吕仁和主编，人民出版社出版)，需要诊断明确，中医辩证清楚，治疗中应用标本缓急恰当，选用处方准确，诊治分虚证(正虚)、实证(邪实)等几十种，对医生的业务素质要求较高。民间对糖病的诊治主要是利尿(《茶酒祛百病》。阎向编著，东方出版社出版)：姜盐茶：觧生姜2片、食盐4.5g、绿茶6g冲水，由于大量的盐份进入体内，会造成心脏负担加重。
本发明的目的是提供一种使用方便，疗效好，无毒附作用的降糖茶。
本发明的实质是在切细绿茶的基础上添加了茶多糖(TPS)、茶多酚(色素)、茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)等微量元素，其配方为：
茶多糖(TPS)≥0.03％(重量百分比，以下同)；
茶多酚(色素)≥10％：
茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)≥1.5％；
切细绿茶其余。
本发明的一个实施例：切细绿茶784.5g、茶多糖0.5g、茶多酚150g、茶儿茶素65g制成1000g粉剂，采用2.5g/袋袋装，；每袋用100～300ml温开水冲泡，每日饮用三次，一个疗程(180袋)，通过检查，降糖总有效率达82.1％，降脂总有效率达91.5％。
本发明的另一个实施例：切细绿茶749g、茶多糖1g、茶多酚200g、茶儿茶素50g、加水9000g制成2000g水剂，采用250g/瓶瓶装；每日饮用三次，每次25g，一个疗程(18瓶)，通过检查，降糖总有效率达81.8％，降脂总有效率大于90％。
本发明是利用切细绿茶的利尿等作用、茶多糖的降血糖、降血脂、抗炎症、降血压等功能、茶多酚的抗氧化、抗基因突变等功效和茶儿茶素的抗脑血管疾病、抗血管粥样硬化等机理，达到标本兼治之目的。加之将降糖茶制成袋装粉剂、水剂或膏剂，方便服用，是预防和治疗糖尿病理想制剂之一。
Claims (3)
1.一种降糖茶由切细绿茶等组成，其特征在于在切细绿茶的基础上添加了茶多糖(TPS)、茶多酚(色素)、茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)等微量元素。
2.根据权利要求1所述的降糖茶，其配方为：
茶多糖(TPS)≥0.03％(重量百分比，下同)；
茶多酚(色素)≥10％；
茶儿茶素(EGCG、EGC、EC、ECG、GC、GCG)≥1.5％；
切细绿茶，其余。
3.根据权利要求1和2所述的降糖茶，其特征在于在权利要求2配方的基础上制成粉剂或加适量的水制成水剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00112591 CN1346642A (zh) | 2000-10-08 | 2000-10-08 | 降糖茶 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00112591 CN1346642A (zh) | 2000-10-08 | 2000-10-08 | 降糖茶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1346642A true CN1346642A (zh) | 2002-05-01 |
Family
ID=4582441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00112591 Pending CN1346642A (zh) | 2000-10-08 | 2000-10-08 | 降糖茶 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1346642A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6967030B2 (en) * | 2003-01-14 | 2005-11-22 | Wright Jonathan V | Formulation for insulin and glucose control |
| CN1792205B (zh) * | 2004-12-24 | 2010-05-12 | 花王株式会社 | 绿茶提取物的精制品及其含高浓度儿茶素的容器装饮料 |
| CN109549987A (zh) * | 2017-09-25 | 2019-04-02 | 株式会社爱茉莉太平洋 | 用于保护细胞免受氧化应激的、包含具有改进量的成分的绿茶提取物的组合物 |
-
2000
- 2000-10-08 CN CN 00112591 patent/CN1346642A/zh active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6967030B2 (en) * | 2003-01-14 | 2005-11-22 | Wright Jonathan V | Formulation for insulin and glucose control |
| CN1792205B (zh) * | 2004-12-24 | 2010-05-12 | 花王株式会社 | 绿茶提取物的精制品及其含高浓度儿茶素的容器装饮料 |
| CN109549987A (zh) * | 2017-09-25 | 2019-04-02 | 株式会社爱茉莉太平洋 | 用于保护细胞免受氧化应激的、包含具有改进量的成分的绿茶提取物的组合物 |
| US11110145B2 (en) | 2017-09-25 | 2021-09-07 | Amorepacific Corporation | Composition for protecting cell from oxidative stress comprising green tea extract which has modified amounts of ingredients |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Williams et al. | Observations on induced thiamine (vitamin B1) deficiency in man | |
| US20190054136A1 (en) | Dietary Supplement for the Treatment of Acid Reflux and Gastro-Oesophageal Reflux Disease (GORD/GERD) | |
| CN101926483A (zh) | 杞菊明目益智保健饮料 | |
| CN107660798A (zh) | 膳食补充剂 | |
| CN108524673A (zh) | 一种中药组合物及其应用 | |
| CN1346642A (zh) | 降糖茶 | |
| CN106822231A (zh) | 具有降血糖功能的生物菌液及其制备方法 | |
| CN104770644A (zh) | 一种基于药食同源的糖尿病保健品 | |
| CN102697135A (zh) | 明目三降功能饮料 | |
| CN111068027B (zh) | 调治阳虚质亚健康的中药组合物及其制备方法和应用 | |
| CN101433356A (zh) | 适于糖尿病人饮用的保健饮料 | |
| CN105147944B (zh) | 一种中药组合物、其制剂及其制备方法和应用 | |
| CN104172166A (zh) | 一种适用于ⅱ型糖尿病人产后的保健粥及其制备方法 | |
| US6103242A (en) | Method of controlling blood sugar levels using Coccoloba uvifera | |
| CN105380277A (zh) | 一种糖尿病人保健饮料 | |
| CN110201100A (zh) | 一种防治三高症、动脉硬化及肥胖症的药食同源组方 | |
| CN115299614B (zh) | 一种解酒组合物、解酒果冻及其制备方法与应用 | |
| CN109395045A (zh) | 一种治疗2型糖尿病湿热中阻证的清热化湿调糖丸及其制备方法 | |
| CN104621304A (zh) | 黄秋葵降糖茶及其生产工艺 | |
| CN101947275B (zh) | 一种用于治疗糖尿病的粉剂及其制备方法 | |
| CN101224256B (zh) | 一种中西药复合降糖药物及其制备方法 | |
| Boyd | The treatment of diabetic coma in children | |
| Sethi | Diabetes Control in your hands | |
| CN1471865A (zh) | 降压醋蜜 | |
| CN119925535A (zh) | 可治疗三高的中草药配方及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |